Table 1. Demographic and clinical overview.
| NMOSD | RRMS | HC | ||
| Subjects | n | 17 | 17 | 17 |
| Gender | Female | 16 | 16 | 16 |
| Male | 1 | 1 | 1 | |
| Age [years] | mean ± SD | 40.8±12.3 | 41.2±12.7 | 41.4±12.4 |
| Min–Max | 19–63 | 20–64 | 21–66 | |
| Time since diagnosis [months] | Mean ± SD | 44.3±38.2 | 93.7±65.8 | n/a |
| Min–Max | 3–129 | 3–240 | n/a | |
| AQP4-Ig positive | n | 16 | n/a | n/a |
| Eyes | n | 34 | 34 | 34 |
| Eyes with a history of ON | n | 20 | 20 | n/a |
| Time since last ON [months] | Mean ± SD | 45±41 | 65±46 | n/a |
| Min–Max | 3–130 | 3–160 | n/a |
Abbreviations: NMOSD: neuromyelitis optica spectrum disorders; RRMS: relapsing-remitting multiple sclerosis; HC: healthy controls; AQP4-Ig: aquaporin 4 antibodies; ON: optic neuritis, n/a = not applicable (the resp. data did not apply to this group).